Mexiletine for treatment of chronic painful diabetic neuropathy.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  The Lancet

• Publication date

  1988-01-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(88)90999-3PMID 2891940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A simple test for autonomic neuropathy in juvenile diabetics.

  2009cited by this paper
• Dercum's disease (adiposis dolorosa). Treatment of the severe pain with intravenous lidocaine.

  1987cited by this paper
• The effect of systemic lidocaine on nociceptive processing in diabetics

  1987cited by this paper
• The analgesic effect of tocainide in trigeminal neuralgia

  1987cited by this paper
• Treatment of chronic painful diabetic neuropathy with intravenous lidocaine infusion.

  1986cited by this paper
• The effect of systemic tocainide, lidocaine and bupivacaine on nociception in the rat

  1985cited by this paper
• Tocainide and mexiletine. Orally effective lidocaine analogues.

  1985cited by this paper
• Imipramine treatment of painful diabetic neuropathy.

  1984cited by this paper
• Mechanism of pain in diabetic peripheral neuropathy. Effect of glucose on pain perception in humans.

  1984cited by this paper
• Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function.

  1983cited by this paper
• Continuous Subcutaneous Insulin Infusion in the Management of Painful Diabetic Neuropathy

  1982cited by this paper
• Mexiletine in plasma by high pressure liquid chromatography.

  1981cited by this paper
• Quantitative determination of hemoglobin A1c by thin-layer isoelectric focusing.

  1980cited by this paper
• Absorption, distribution and elimination of mexiletine.

  1977cited by this paper
• Graphic representation of pain

  1976cited by this paper
• Molecular Mechanisms of Nerve Block by Local Anesthetics

  1976cited by this paper
• Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial.

  1969cited by this paper

• Towards development of Nav1.7 channel modulators for pain treatment: A comparison of mexiletine effect in two cell models by automated patch clamp.

  2025cites this paper
• Discordance between preclinical and clinical testing of NaV1.7-selective inhibitors for pain

  2024cites this paper
• In vivo analgesic activity of new N-arylphthalimides derivatives in mice.

  2023cites this paper
• Evaluation of Vibrational, Electronic, Topology, Reactivity, Bioactivity, Bioavailability and Blood-Brain Barrier Score of 1-(2,6-dimethylphenoxy)propan-2-amine-A DFT, Spectro-scopic and Molecular Docking Approach

  2022cites this paper
• A secondary analysis of PAIN‐CONTRoLS: Pain's impact on sleep, fatigue, and activities of daily living

  2022cites this paper
• Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.

  2020cites this paper
• Chronic inflammatory demyelinating polyradiculoneuropathy relapse after mexiletine withdrawal in a patient with concomitant myotonia congenita

  2020cites this paper
• Diabetic Peripheral Neuropathy: Diagnosis and Treatment.

  2020cites this paper
• Membrane Stabilizer Medications in the Treatment of Chronic Neuropathic Pain: a Comprehensive Review

  2019cites this paper
• Treatment :: Peripheral and Autonomic Neuropathies

  2019cites this paper
• Analgesic effects of amiodarone in mouse models of pain

  2019cites this paper
• The Effect of Sodium Channel Blocker, Mexiletine, on Body Weight in Type 2 Diabetes Patients with Visceral Obesity

  2019cites this paper
• Mexiletine Usage in a Chronic Pain Clinic: Indications, Tolerability, and Side Effects.

  2018cites this paper
• Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials

  2017cites this paper
• High-frequency ventilation for non-invasive respiratory support of neonates.

  2016cites this paper
• Antiarrhythmic Mexiletine: A Review on Synthetic Routes to Racemic and Homochiral Mexiletine and its Enantioseparation.

  2016cites this paper
• 35Cl solid-state NMR spectroscopy of HCl pharmaceuticals and their polymorphs in bulk and dosage forms

  2016cites this paper
• Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis

  2016cites this paper
• Voltage-Gated Ion Channels in the PNS: Novel Therapies for Neuropathic Pain?

  2016cites this paper
• Daily oral iron supplementation during pregnancy.

  2015cites this paper
• Pharmacological treatment of diabetic peripheral neuropathy.

  2015cites this paper
• Pulmonary arteriovenous malformation in children

  2015cites this paper
• Antihyperalgesic effects of ProTx-II, a Nav1.7 antagonist, and A803467, a Nav1.8 antagonist, in diabetic mice

  2015cites this paper
• Erythromelalgia with a linear pattern in a 12‐year‐old girl

  2015cites this paper
• Diabetic Peripheral Neuropathy: Current Concepts and Future Perspectives

  2015cites this paper
• Conotoxins That Could Provide Analgesia through Voltage Gated Sodium Channel Inhibition

  2015cites this paper
• Systematic Review and Meta‐Analysis of Pharmacological Therapies for Painful Diabetic Peripheral Neuropathy

  2014cites this paper
• Painful diabetic neuropathy

  2014cites this paper
• Pharmacologic Interventions for Painful Diabetic Neuropathy

  2014cites this paper
• Fentanyl produces an anti-hyperalgesic effect through the suppression of sodium channels in mice with painful diabetic neuropathy.

  2014cites this paper
• Standard and emerging treatment options for diabetic neuropathy.

  2014cites this paper
• Diabetic neuropathy part 1: overview and symmetric phenotypes.

  2013cites this paper
• Anticonvulsant Agents Used for Neuropathic Pain Including Trigeminal Neuralgia

  2013cites this paper
• Considerations for neuropathic pain conditions in life care planning.

  2013cites this paper
• A COMPARATIVE STUDY OF ANALGESIC ACTIVITY OF FLUOXETINE WITH IBUPROFEN AND PENTAZOCINE IN RODENT MODELS

  2013cites this paper
• Review Article Recent and emerging trends in Pharmacotherapy of neuropathic pain

  2013cites this paper
• Fluoxetine, Pentazocine, Ibuprofen, Rodent Model, Hot-plate Method.

  2013cites this paper
• Diabetic Neuropathy and Oxidative Stress: Therapeutic Perspectives

  2013cites this paper
• Impact of treatments for painful diabetic polyneuropathies on patients

  2013cites this paper
• Peripheral Diabetic Neuropathy Current Recommendations and Future Prospects for its Prevention and Management

  2012cites this paper
• Discovery and optimization of aminopyrimidinones as potent and state-dependent Nav1.7 antagonists.

  2012cites this paper
• Adjuvant Analgesics in Cancer Pain: A Review

  2012cites this paper
• Painful Diabetic Neuropathy in Clinical Practice

  2011cites this paper
• Strictly defined familial male breast cancer

  2011cites this paper
• Management of Neuropathic Pain

  2011cites this paper
• 1 – Introduction to Assisted Ventilation

  2011cites this paper
• Evidence‐based Guideline: Treatment of Painful Diabetic Neuropathy

  2011cites this paper
• Primary Erythromelalgia in a 12-Year-Old Boy: Positive Response to Sodium Channel Blockers Despite Negative SCN9A Mutations

  2011cites this paper
• Mexiletine reverses oxaliplatin-induced neuropathic pain in rats.

  2010cites this paper
• Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism

  2010cites this paper
• Eficacia de la administración de antioxidantes, solos y en combinación con gabapentina, en un modelo experimental de dolor neuropático en ratas

  2010cites this paper
• Studies of synergy between morphine and a novel sodium channel blocker, CNSB002, in rat models of inflammatory and neuropathic pain.

  2010cites this paper
• Diabetic neuropathy: still a challenge in pharmacology.

  2010cites this paper
• Mexiletine suppresses nodal persistent sodium currents in sensory axons of patients with neuropathic pain.

  2010cites this paper
• Pharmacological and interventional treatments for neuropathic pain

  2009cites this paper
• Sodium channel blockers for the treatment of neuropathic pain

  2009cites this paper
• Schmerztherapie und Symptomkontrolle in der Palliativmedizin

  2009cites this paper
• Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study.

  2009cites this paper
• Managing Opioid-Induced Hyperalgesia in the Perioperative Period

  2009cites this paper
• Experience with oral mexiletine in primary erythromelalgia in children

  2009cites this paper
• Dolore neuropatico post-chirurgico

  2009cites this paper
• CHAPTER 3 – NEUROPATHIC PROBLEMS OF THE LOWER LIMBS IN DIABETIC PATIENTS

  2008cites this paper
• Capítulo 3 – Problemas neuropáticos de los miembros inferiores en los pacientes diabéticos

  2008cites this paper
• Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat

  2008cites this paper
• Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options.

  2008cites this paper
• Oral and dental adverse drug reactions.

  2008cites this paper
• Pharmacologic intervention in axonal excitability: in vivo assessment of nodal persistent sodium currents in human neuropathies.

  2008cites this paper
• The role of tetrodotoxin-resistant sodium channels in pain states: are they the next target for analgesic drugs?

  2008cites this paper
• The pharmacotherapy of chronic pain.

  2008cites this paper
• Dercum’s disease (Lipomatosis dolorosa): successful therapy with pregabalin and manual lymphatic drainage and a current overview

  2008cites this paper
• Morphine versus Mexiletine for Treatment of Postamputation Pain: A Randomized, Placebo-controlled, Crossover Trial

  2008cites this paper
• Rôle des canaux sodium des neurones afférents primaires dans les douleurs neuropathiques périphériques

  2008cites this paper
• Flecainide for the treatment of chronic neuropathic pain: a Phase II trial

  2007cites this paper
• Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double blind placebo controlled cross-over study.

  2007cites this paper
• Pharmacotherapy in Diabetic Neuropathy

  2007cites this paper
• An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.

  2007cites this paper
• Painful Diabetic Neuropathy: A Management-Centered Review

  2007cites this paper
• chapter 29 – Identification and Treatment of Cancer Pain Syndromes

  2007cites this paper
• Management of Pain in Skeletal Metastases

  2006cites this paper
• Effect of mexiletine on vincristine-induced painful neuropathy in mice.

  2006cites this paper
• Tratamiento farmacológico del dolor neuropático

  2006cites this paper
• Treatment of intractable painful diabetic neuropathy with intravenous lignocaine.

  2006cites this paper
• Medikamentöse Therapie von Tumorschmerzen

  2006cites this paper
• Guías ALAD 2006 de diagnóstico control y tratamiento de la Diabetes Mellitus Tipo 2.

  2006cites this paper
• CHAPTER 12 – Postherpetic Neuralgia in the Cancer Patient

  2006cites this paper
• Ion channel targets and treatment efficacy in neuropathic pain.

  2006cites this paper
• The pharmacotherapy of chronic pain: a review.

  2006cites this paper
• Antinociceptive Effects of Mexiletine Hydrochloride on Painful Diabetic Neuropathy Through the Enhancement of β-endorphin Levels in the Midbrain

  2006cites this paper
• Voltage‐gated sodium channels as molecular targets for neuropathic pain

  2006influential citation
• CHAPTER 24 – Topical and Oral Anesthetics

  2006cites this paper
• Pharmacological therapy for neuropathic pain

  2006cites this paper
• Sodium channel blockers in neuropathic pain.

  2005cites this paper
• Painful diabetic neuropathy

  2005cites this paper
• Effect of sodium channel blocker (mexiletine) on pathological ectopic firing pattern in a rat chronic constriction nerve injury model

  2005cites this paper
• Systemic administration of local anesthetic agents to relieve neuropathic pain.

  2005cites this paper
• The effects of mexiletine on excitability properties of human median motor axons.

  2005cites this paper
• The Treatment of Neuropathic Pain

  2005cites this paper
• Pharmacotherapeutic options in pain management.

  2005cites this paper
• Newer agents for the treatment of painful diabetic peripheral neuropathy

  2005cites this paper
• Critical review of oral drug treatments for diabetic neuropathic pain—clinical outcomes based on efficacy and safety data from placebo‐controlled and direct comparative studies

  2005influential citation